Novo Nordisk A/S (NVO) Stock Chart & Stock Price History $78.74 -4.33 (-5.22%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Novo Nordisk A/S Stock Price Performance 5 Day Performance-5.12%1 Month Performance-7.37%3 Month Performance-33.32%6 Month Performance-40.14%Year-To-Date Performance-8.47%1 Year Performance-26.39% Receive NVO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address NVO Stock Chart for Monday, January, 20, 2025 NVO Chart by TradingView Novo Nordisk A/S Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$83.26$78.74-5.43%$80.88$78.1721.24 million shs$372.78 billion01/16/2025$82.99$83.26+0.32%$83.99$82.196.32 million shs$373.61 billion01/15/2025$81.27$82.99+2.12%$83.82$82.719.02 million shs$372.42 billion01/14/2025$84.43$81.27-3.74%$83.68$80.0513.69 million shs$364.70 billion01/13/2025$86.41$84.43-2.29%$84.72$83.697.41 million shs$378.88 billion01/10/2025$85.63$86.41+0.91%$87.28$85.846.77 million shs$387.77 billion01/09/2025$85.63$85.63$85.80$84.689.19 million shs$384.27 billion01/08/2025$83.19$85.63+2.93%$85.80$84.689.19 million shs$384.27 billion01/07/2025$84.95$83.19-2.07%$84.81$82.649.56 million shs$373.32 billion01/06/2025$87.65$84.95-3.08%$86.34$84.8010.68 million shs$381.22 billion Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 01/03/2025$87.52$87.65+0.15%$88.19$87.343.76 million shs$393.33 billion01/02/2025$86.02$87.52+1.74%$88.51$87.184.57 million shs$392.75 billion01/01/2025$86.02$86.02$86.05$85.004.20 million shs$386.02 billion12/31/2024$85.73$86.02+0.34%$86.05$85.004.20 million shs$386.02 billion12/30/2024$87.37$85.73-1.88%$87.00$85.666.10 million shs$384.72 billion12/27/2024$87.65$87.37-0.32%$88.77$87.026.06 million shs$392.08 billion12/26/2024$87.37$87.65+0.32%$88.06$86.876.29 million shs$393.33 billion12/25/2024$87.37$87.37$88.98$87.074.77 million shs$392.08 billion12/24/2024$88.71$87.37-1.51%$88.98$87.074.77 million shs$392.08 billion12/23/2024$85.00$88.71+4.36%$89.10$85.9918.98 million shs$398.09 billion12/20/2024$103.44$85.00-17.83%$86.53$81.5053.56 million shs$381.44 billion12/19/2024$105.96$103.44-2.38%$104.75$102.745.12 million shs$464.19 billion Related Companies AstraZeneca Stock Chart Novartis Stock Chart Sanofi Stock Chart GSK Stock Chart Takeda Pharmaceutical Stock Chart argenx Stock Chart BioNTech Stock Chart Teva Pharmaceutical Industries Stock Chart BeiGene Stock Chart Summit Therapeutics Stock Chart Receive NVO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NVO) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVO Stock Alerts